Funds holding XILIO THERAPEUTICS INC
ISIN US98422T1007 · United States
- Fund holders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 142.1K $
- Share of capital
- 4.7 % of 5.8M shares on Mar 18, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 141,896 | 75K $ | 0.00 % | 2.45 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 63,207 | 33.4K $ | 1.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 49,584 | 26.2K $ | 0.86 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 14,316 | 7.6K $ | 0.25 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | -4 | 269,003 | -81.0 % |
| 2026Q1 | 8 | 0 | 1,418,137 | -2.9 % |
| 2025Q4 | 8 | +1 | 1,461,232 | -4.3 % |
| 2025Q3 | 7 | -2 | 1,527,266 | -3.8 % |
| 2025Q2 | 9 | 0 | 1,588,155 | +17.7 % |
| 2025Q1 | 9 | 0 | 1,349,277 | +11.1 % |
| 2024Q4 | 9 | -2 | 1,214,426 | +9.8 % |
| 2024Q3 | 11 | +1 | 1,105,750 | +0.4 % |
| 2024Q2 | 10 | -2 | 1,101,289 | -7.3 % |
| 2024Q1 | 12 | -4 | 1,188,174 | +3.3 % |
| 2023Q4 | 16 | 1,150,403 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 650,389 | 5.5M $ | as of Mar 31, 2026 |
Declared shareholders of XILIO THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Sirenia Capital Management LP and 1 other | 9.90 % | 1,142,862 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 0.00 % | 0 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding XILIO THERAPEUTICS INC". https://titelia.com/en/stocks/xilio-therapeutics-inc-US98422T1007